BDTX
Black Diamond Therapeutics Inc
Price:  
3.21 
USD
Volume:  
984,134
United States | Biotechnology

BDTX Gross Margin

As of 2025-07-18, the Gross Margin of Black Diamond Therapeutics Inc (BDTX) is 7775.2%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BDTX Gross Margin - Historical Value
DateValue
2024-12-31 7775.2%
2023-12-31 -
2022-12-31 -
2021-12-31 -
2020-12-31 -
2019-12-31 -
2018-12-31 -
2017-12-31 -
-
-
BDTX Gross Margin - Peers Comparison